Preliminary melanoma plans
Immunicum announced preliminary plans to conduct two separate studies with INTUVAX for the treatment of advanced melanoma in combination with immune checkpoint inhibitors, one in first line treatment, the other one as second line treatment, in the U.S. and Sweden respectively.
Read the press release here: Press release 160623 – Info melanoma studies
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805